SINGAPORE: Shares of Biolidics Ltd. jumped as the Singapore-based medical device manufacturer said its rapid test kits for Covid-19 were approved for sale in the European Union.
The stock rose as much as 12% in early trading after the firm announced on Monday that it received confirmation for CE marking on Friday. CE marking is a notification process to authorities which enables companies to market and sell products in the EU.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!